Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Adenocarcinoma and CD44[original query] |
---|
Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma. International journal of cancer. Journal international du cancer 2011 Sep 129 (5): 1096-104. Winder Thomas, Ning Yan, Yang Dongyun, Zhang Wu, Power Derek G, Bohanes Pierre, Gerger Armin, Wilson Peter M, Lurje Georg, Tang Laura H, Shah Manish, Lenz Heinz-Jos |
Stromal micropapillary component as a novel unfavorable prognostic factor of lung adenocarcinoma. Diagnostic pathology 2012 7 (1): 3. Ohe Miki, Yokose Tomoyuki, Sakuma Yuji, Miyagi Yohei, Okamoto Naoyuki, Osanai Sachie, Hasegawa Chikako, Nakayama Haruhiko, Kameda Yoichi, Yamada Kouzo, Isobe Takes |
CD44 SNPrs187115: A Novel Biomarker Signature that Predicts Survival in Resectable Pancreatic Ductal Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Jun . Stracquadanio Giovanni, Vrugt Bart, Flury Renata, Schraml Peter, Würl Peter, Müller Thomas H, Knippschild Uwe, Henne-Bruns Doris, Breitenstein Stefan, Clavien Pierre-Alain, Graf Rolf, Bond Gareth L, Grochola Lukasz |
KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer. Cancer biomarkers : section A of Disease markers 2016 Mar . Ribeiro Karen Bento, da Silva Zanetti Juliana, Ribeiro-Silva Alfredo, Rapatoni Liane, de Oliveira Harley Francisco, da Cunha Tirapelli Daniela Pretti, Garcia Sergio Britto, Feres Omar, da Rocha José Joaquim Ribeiro, Peria Fernanda Mar |
Colorectal carcinoma with osseous metaplasia. Oncotarget 2017 Sep 8 (39): 65407-65413. Liu Xibo, Xu Jinghong, Chen Liro |
Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants. JAMA surgery 2019 Apr e190484. Dimitrakopoulos Christos, Vrugt Bart, Flury Renata, Schraml Peter, Knippschild Uwe, Wild Peter, Hoerstrup Simon, Henne-Bruns Doris, Wuerl Peter, Graf Rolf, Breitenstein Stefan, Bond Gareth, Beerenwinkel Niko, Grochola Lukasz Fil |
The Significance of CD44 Variant 9 in Resected Lung Adenocarcinoma: Correlation with Pathological Early-Stage and EGFR Mutation. Annals of surgical oncology 2019 2 26 (5): 1544-1551. Akamine Takaki, Tagawa Tetsuzo, Ijichi Kayo, Toyokawa Gouji, Takamori Shinkichi, Hirai Fumihiko, Okamoto Tatsuro, Oda Yoshinao, Maehara Yoshihi |
CD44 Gene Polymorphisms as a Risk Factor for Susceptibility and Their Effect on the Clinicopathological Characteristics of Lung Adenocarcinoma in Male Patients. International journal of environmental research and public health 2020 Apr 17 (9): . Li Ju-Pi, Hsieh Ming-Ju, Chou Ying-Erh, Chao Yu-Hua, Tsao Thomas Chang-Yao, Yang Shun- |
Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival. Scientific reports 2021 Apr 11 (1): 7570. Gentiluomo Manuel, Corradi Chiara, Vanella Giuseppe, Johansen Astrid Z, Strobel Oliver, Szentesi Andrea, Milanetto Anna Caterina, Hegyi Péter, Kupcinskas Juozas, Tavano Francesca, Neoptolemos John P, Bozzato Dania, Hackert Thilo, Pezzilli Raffaele, Johansen Julia S, Costello Eithne, Mohelnikova-Duchonova Beatrice, van Eijck Casper H J, Talar-Wojnarowska Renata, Hansen Carsten Palnæs, Darvasi Erika, Chen Inna M, Cavestro Giulia Martina, Soucek Pavel, Piredda Liliana, Vodicka Pavel, Gazouli Maria, Arcidiacono Paolo Giorgio, Canzian Federico, Campa Daniele, Capurso Gabrie |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: